Induction of apoptosis in myeloid progenitors by granulocyte-macrophage colony-stimulating factor

被引:0
|
作者
Alenzi, FQB [1 ]
机构
[1] King Faisal Univ, Coll Appl Med Sci, Dept Med Lab Sci, Dammam 31451, Saudi Arabia
关键词
antigens; CD34; apoptosis; caspases; cytokines; fluorescent antibody technique; granulocyte-macrophage colony-stimulating factor; in situ nick-end labeling;
D O I
10.1080/09674845.2004.11732672
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Spontaneous apoptosis of normal purified bone marrow CD34(+) cells induced by granulocyte-macrophage colony-stimulating factor (GM-CSF) via the Fas pathway appears to be mediated by caspase-1 and caspase-8 activity. In seeking an alternative explanation for this observation, the present study examined CD34(+) cell growth with different cytokines, cytokine concentrations, caspase inhibitors, cell crowding and different media. Exposure of the normal CD34(+) cells to different concentrations of GMCSF and granulocyte colony-stimulating factor (G-CSF) increased apoptosis at lower concentrations. However, these GM-CSF effects were suppressed by G-CSF Investigation of the association between apoptosis and crowding and different media showed that: 1) G-CSF and GM-CSF are equally effective as survival factors, and 2) the percentage of apoptotic cells in liquid culture was markedly lower than that found in methylcellulose culture. Finally, immunofluorescence staining showed that Fas was expressed at 10 ng/mL GM-CSF, while Bcl-2 expression was detected at 100 ng/mL. These findings suggest that cytokine concentration, cell culture conditions, cell crowding and cell interactions all are important factors in GM-CSF-induced apoptosis.
引用
收藏
页码:200 / 205
页数:6
相关论文
共 50 条
  • [1] Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor in the treatment of acute myeloid leukemia and acute lymphoblastic leukemia
    Ohno, R
    LEUKEMIA RESEARCH, 1998, 22 (12) : 1143 - 1154
  • [2] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PSORIASIS
    TAKEMATSU, H
    TAGAMI, H
    DERMATOLOGICA, 1990, 181 (01): : 16 - 20
  • [3] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN ACUTE NONLYMPHOCYTIC LEUKEMIA
    FANIN, R
    BACCARANI, M
    JOURNAL OF INTERNAL MEDICINE, 1994, 236 (05) : 487 - 493
  • [4] Granulocyte-macrophage colony-stimulating factor and the immune system
    Tarr, PE
    MEDICAL ONCOLOGY, 1996, 13 (03): : 133 - 140
  • [5] Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome
    Matute-Bello, G
    Liles, WC
    Radella, F
    Steinberg, KP
    Ruzinski, JT
    Hudson, LD
    Martin, TR
    CRITICAL CARE MEDICINE, 2000, 28 (01) : 1 - 7
  • [6] LEVELS OF HUMAN SERUM GRANULOCYTE COLONY-STIMULATING FACTOR AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR UNDER PATHOLOGICAL CONDITIONS
    OMORI, F
    OKAMURA, S
    SHIMODA, K
    OTSUKA, T
    HARADA, M
    NIHO, Y
    BIOTHERAPY, 1992, 4 (02) : 147 - 153
  • [7] Granulocyte-macrophage colony-stimulating factor: inhibitor of tumor necrosis factor-induced apoptosis
    Quentmeier, H
    Reinhardt, J
    Zaborski, M
    Drexler, HG
    LEUKEMIA RESEARCH, 2003, 27 (06) : 539 - 545
  • [8] CDNA CLONING OF PORCINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
    INUMARU, S
    TAKAMATSU, H
    IMMUNOLOGY AND CELL BIOLOGY, 1995, 73 (05): : 474 - 476
  • [9] SPECIFIC HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ANTAGONISTS
    HERCUS, TR
    BAGLEY, CJ
    CAMBARERI, B
    DOTTORE, M
    WOODCOCK, JM
    VADAS, MA
    SHANNON, MF
    LOPEZ, AF
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (13) : 5838 - 5842
  • [10] Granulocyte-macrophage colony-stimulating factor activity in cerebrospinal fluid
    Leonardi, A
    Penco, S
    Gramigni, C
    Bason, C
    Ribizzi, G
    Gazzola, P
    Mancardi, GL
    Bianchi-Scarrà, G
    Abbruzzese, M
    Garrè, C
    ACTA NEUROLOGICA SCANDINAVICA, 1999, 100 (04): : 274 - 277